PEDIMED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PEDIMED
Largest movements
- Current investments +€56,322
up €56,322 (+50.0%), from €112,644 to €168,965
- Cash -€14,997
down €14,997 (-7.5%), from €199,725 to €184,728
mainly Current investments (-€56,322) and Contributions, distributions and other (-€45,000)
- Reserves +€53,000
up €53,000 (+19.0%), from €278,860 to €331,860
- Tax, wage and social debts -€12,894
down €12,894 (-48.6%), from €26,556 to €13,662
- Gross operating margin -€40,426
down €40,426 (-21.3%), from €189,854 to €149,429
- Taxes -€8,966
down €8,966 (-16.4%), from €54,806 to €45,841
- Depreciation -€2,049
down €2,049 (-58.6%), from €3,496 to €1,447
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €316,830 | €356,110 | +€39,280 | +12.4% |
| Fixed assets | 21/28 | €1,447 | - | -€1,447 | |
| Tangible fixed assets | 22/27 | €1,447 | - | -€1,447 | |
| Furniture and vehicles | 24 | €1,447 | - | -€1,447 | |
| Current assets | 29/58 | €315,383 | €356,110 | +€40,727 | +12.9% |
| Current investments | 50/53 | €112,644 | €168,965 | +€56,322 | +50.0% |
| Cash at bank and in hand | 54/58 | €199,725 | €184,728 | -€14,997 | -7.5% |
| Deferred charges and accrued income | 490/1 | €3,015 | €2,417 | -€598 | -19.8% |
| Total equity and liabilities | 10/49 | €316,830 | €356,110 | +€39,280 | +12.4% |
| Equity | 10/15 | €285,471 | €339,322 | +€53,851 | +18.9% |
| Contributions | 10/11 | €6,250 | €6,250 | = | 0.0% |
| Reserves | 13 | €278,860 | €331,860 | +€53,000 | +19.0% |
| Distributable reserves | 133 | €278,860 | €331,860 | +€53,000 | +19.0% |
| Profit (loss) carried forward | 14 | €361 | €1,212 | +€851 | +235.8% |
| Amounts payable | 17/49 | €31,359 | €16,788 | -€14,572 | -46.5% |
| Amounts payable within one year | 42/48 | €31,359 | €16,788 | -€14,572 | -46.5% |
| Trade debts | 44 | €3,789 | €1,663 | -€2,125 | -56.1% |
| Suppliers | 440/4 | €3,789 | €1,663 | -€2,125 | -56.1% |
| Taxes, remuneration and social security | 45 | €26,556 | €13,662 | -€12,894 | -48.6% |
| Taxes | 450/3 | €26,556 | €13,662 | -€12,894 | -48.6% |
| Other amounts payable | 47/48 | €1,014 | €1,462 | +€448 | +44.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,496 | €1,447 | -€2,049 | -58.6% |
| Other operating charges | 640/8 | €942 | €667 | -€275 | -29.2% |
| Gross operating margin | 9900 | €189,854 | €149,429 | -€40,426 | -21.3% |
| Operating profit (loss) | 9901 | €185,416 | €147,314 | -€38,102 | -20.5% |
| Financial income | 75/76B | €1,133 | €2,096 | +€962 | +84.9% |
| Recurring financial income | 75 | €1,133 | €2,096 | +€962 | +84.9% |
| Financial charges | 65/66B | €4,485 | €4,718 | +€233 | +5.2% |
| Recurring financial charges | 65 | €4,485 | €4,718 | +€233 | +5.2% |
| Profit (loss) for the period before taxes | 9903 | €182,065 | €144,692 | -€37,373 | -20.5% |
| Income taxes | 67/77 | €54,806 | €45,841 | -€8,966 | -16.4% |
| Profit (loss) for the period | 9904 | €127,258 | €98,851 | -€28,407 | -22.3% |
| Profit (loss) for the period to be appropriated | 9905 | €127,258 | €98,851 | -€28,407 | -22.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.